ClinicalTrials.gg
Not yet recruitingNCT07498348Updated Oct 6, 2026

Apple Watch Evaluation of Endodontics Occupational Stress

An observational study in Occupational Stress, sponsored by University of Illinois at Chicago. Not yet recruiting at 1 site in United States. Per ClinicalTrials.gov, last updated 2026-10-06.

Sponsored by University of Illinois at Chicago · Observational

How we know

Updated Oct 6, 2026Start date movedPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
12
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 61 studies in Occupational Stress with a site in United States — 10 open to participants now, 13 under way, none of them phase 3. Occupational Stress · United States.

Started
2027
with 1 other
Observational
7 of 61
4 open now
Primary completion
2028-05
later than 7 of 12 live
Registered
55th of 61
by date
Lead sponsor
2 of 61
University of Illinois at Chicago

Among the 61 studies in Occupational Stress with a site in United States, this one is one of 2 that started in 2027, is one of 7 observational ones, reaches primary completion later than 7 of the 12 other live ones, and was the 55th registered.

Occupational Stress

238 studies on the registry are indexed under Occupational Stress; 64 are open to participants now.

Browse Occupational Stress studies →

Open to participants now

10 of the 61 studies in Occupational Stress with a site in United States are open now. Recruiting first, the newest first:

4 more — sign in →

All 10 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 33 Occupational Stress studies recruiting now, 17 (52%) set no upper age limit and 13 (39%) stop at 75 or younger; 4 take children under 18; 25 take healthy volunteers.

This study: all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 61 studies in Occupational Stress with a site in United States, or all of them as a file.
02

Study summary

  • This study will enroll approximately 12 endodontists (primary subjects) and approximately 120 patients (secondary subjects) undergoing routine endodontic treatment (primary root canal treatment or retreatment), resulting in approximately 120 observed treatment sessions. Patients will be treated as part of standard clinical care and will not receive any experimental intervention.
  • Participating endodontists will wear an Apple Watch to continuously monitor heart rate (HR) during routine endodontic procedures. The Apple Watch contains built-in physiological sensors that automatically record heart rate. HR data are stored locally in the Apple Health app on a study-designated iPhone assigned for research use and handled solely by the Principal Investigator (PI). No real-time data transmission or cloud-based sharing occurs during data recording. At designated intervals, the PI will use the Apple Health app's built-in "Export Health Data" function, which generates a ZIP file containing an export.xml file with sensor-recorded data. The ZIP file will be uploaded directly from the study iPhone to a secure, university-approved UI Box Health Data Folder designated for the study. No research-specific Apple ID, cloud account, or third-party data-sharing platform will be used.
  • A trained, non-intervening observer will record start and stop timepoints of predefined endodontic treatment stages to align HR signals with procedural phases. These stages include patient presentation, examination, informed consent, local anesthesia administration, rubber dam placement, access cavity preparation, root canal instrumentation, obturation, and final radiographic assessment. The observer will document only minimal, non-identifiable procedural variables necessary for analysis, including treatment type (primary root canal treatment or retreatment), treatment difficulty level (based on the AAE Endodontic Case Difficulty Assessment), and patient age category. No patient identifiers or protected health information (PHI) will be recorded.
  • Each participating endodontist will complete the Perceived Stress Questionnaire (PSQ) two times in total at baseline and at the conclusion of study participation to assess perceived stress levels and evaluate associations between baseline stress and physiological stress responses during treatment. The PSQ requires approximately 5 minutes to complete. Endodontists will not complete questionnaires for individual patient encounters. HR data and permitted procedural variables will be coded, securely stored in the UI Box Health Data Folder, and analyzed to assess HR variation across endodontic treatment stages and treatment difficulty levels. No additional patient identifiers or PHI will be collected beyond what is specified above.
03

Conditions studied

  • Occupational Stress

Browse trials for

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

A total of approximately 132 subjects will be enrolled in this study, consisting of approximately 12 endodontics (primary subjects) and approximately 120 patients (secondary subjects). Each participating endodontics will be observed during approximately 10 endodontic treatment sessions, resulting in an estimated total of 120 clinical sessions for data collection. Each patient will participate in one clinical encounter only, while resident participation will continue throughout the data collection period.

Eligibility criteria

Inclusion Criteria for Primary Subjects (endodontics residents) :

  • Active enrollment in an accredited endodontics residency program during the data-collection period
  • Routine clinical involvement in primary root canal treatment and/or retreatment
  • Willingness to wear a wrist-worn heart rate monitoring device during clinical sessions
  • Willingness to complete the Perceived Stress Questionnaire (PSQ) at baseline and at the conclusion of participation
  • Absence of medical or dermatologic conditions that would preclude safe or accurate wrist-worn heart rate monitoring

Inclusion Criteria for secondary Subjects (Patients):

  • Scheduled to receive standard endodontic care with a participating endodontics resident during the study period
  • Willingness to allow the presence of a non-intervening observer
  • Willingness to allow collection of minimal, approved visit-level variables
  • Adult patients able to provide written
  • Minor patients (under 18 years of age) with parent or legally authorized representative permission
  • Assent obtained from minors as follows:
  • Verbal assent for minors aged 7-12 years
  • Written assent for minors aged 13-17 years
  • No formal assent required for children under 7 years of age (developmentally appropriate explanation provided when feasible)
  • Ability of patient or legally authorized representative to understand and communicate in English

Exclusion Criteria for Primary Subjects (endodontics residents) :

  • Not engaged in clinical endodontic care during the study window
  • Known dermatologic, cardiovascular, neurologic, or other medical conditions that could interfere with safe or accurate heart rate monitoring
  • Unwilling or unable to provide informed consent or comply with study procedures

Exclusion Criteria for secondary Subjects (Patients):

  • Decline consent, permission, or assent
  • Withdraw participation at any time
  • Prisoners or individuals under custodial supervision
  • Pregnant patients
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
12 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients need Root canal treatment
06

What researchers measure

Primary outcomes

  1. The change in heart rate (HR) of endodontists measured across predefined stages of endodontic treatment.

    Time frame: Periprocedural

07

Study locations

1 site
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2027; primary completion for May 2028, 9 months later.

Of 27 observational studies under Occupational Stress, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 41. This study's planned 9 months is below that.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 6, 2026: start Aug 2026 → Aug 2027, primary completion May 2027 → May 2028 and completion Jun 2027 → Jun 2029.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Mar 8, 2026
First posted
Mar 27, 2026
StartEst.
Aug 1, 2027was Aug 2026
Primary completionEst.
May 15, 2028was May 2027
CompletionEst.
Jun 15, 2029was Jun 2027
Last update
Oct 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Aug 1, 2026→Aug 1, 2027
Oct 6, 2026
Primary completion
May 15, 2027→May 15, 2028
Oct 6, 2026
Study completion
Jun 15, 2027→Jun 15, 2029
Oct 6, 2026
Show all 1 update
  1. Oct 6, 2026
    Start date Aug 1, 2026→Aug 1, 2027
    Primary completion May 15, 2027→May 15, 2028
    Study completion Jun 15, 2027→Jun 15, 2029
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07498348
Responsible party
Shlomo Elbahary (Clinical Associate Professor, University of Illinois at Chicago) — Principal investigator
First posted
Mar 27, 2026
Start date
Aug 1, 2027 (estimated)
Primary completion
May 15, 2028 (estimated)
Completion
Jun 15, 2029 (estimated)
Last update
Oct 6, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion